Nurse Practitioner, Women’s Health · Richmond, VA
NPI
1861855751
Since 2016
Specialty
Nurse Practitioner, Women’s Health
Code 363LW0102X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
9101 Stony Point Dr
Richmond, VA, 23235
Phone (804) 330-9105
Groups this clinician bills Medicare through
Medicare paid, 2024
$33K
1,961 services
Medicare patients, 2024
257
Average age 78
Drug cost, 2024
$567K
2,695 prescriptions
Company payments, 2025
$2,923
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kara M Parker was code 99214 (office e&m - established), 184 times for 167 patients. In total Kara M Parker billed 1,961 services in 24 codes, and Medicare paid $33K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-03-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 184 | 167 | $84.06 | $15K |
| 51798 Ultrasound - Nonspecific | Office | 103 | 97 | $8.77 | $903 |
| 81000 Clinical Chemistry | Office | 95 | 88 | $3.87 | $368 |
| 81002 Clinical Chemistry | Office | 75 | 70 | $3.41 | $256 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 74 | 70 | $10.72 | $793 |
| 99204 Office E&M - New | Office | 48 | 48 | $109.00 | $5,232 |
| 99213 Office E&M - Established | Office | 29 | 29 | $58.76 | $1,704 |
By year: 2022 $8,941 for 588 services; 2023 $18K for 1,042 services; 2024 $33K for 1,961 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81000 Clinical Chemistry | 95 | 88 | $3.87 | $368 |
| 81002 Clinical Chemistry | 75 | 70 | $3.41 | $256 |
Medicare prescription drug claims, 2024
In 2024, the drug Kara M Parker prescribed most often to Medicare patients was Gemtesa (Vibegron), with 365 prescriptions and refills. In total Kara M Parker wrote 2,695 Medicare prescriptions that cost $567K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gemtesa Vibegron | 365 | 573 | 89 | $267K |
| Methenamine Hippurate Generic | 323 | 481 | 89 | $19K |
| Estradiol Generic | 300 | 704 | 183 | $22K |
| Myrbetriq Mirabegron | 295 | 402 | 71 | $179K |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 290 | 292 | 243 | $2,938 |
| Trospium Chloride Generic | 192 | 325 | 59 | $11K |
| Trospium Chloride Er Trospium Chloride | 167 | 285 | 58 | $27K |
| Cephalexin Generic | 119 | 162 | 50 | $917 |
| Ciprofloxacin Hcl Generic | 102 | 102 | 83 | $348 |
| Cefuroxime Cefuroxime Axetil | 93 | 93 | 82 | $1,390 |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 58 | 66 | 25 | $1,358 |
| Trimethoprim Generic | 37 | 43 | 14 | $1,542 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 37 | 37 | 35 | $250 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 29 | 29 | 24 | $115 |
| Mirabegron Er Mirabegron | 29 | 49 | 14 | $15K |
Brand drugs: - claims; generic drugs: 1,873 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kara M Parker $2,923 ($2,923 in general payments such as food, travel and fees) from 24 companies. The largest payer was Sumitomo Pharma America, Inc. with $691.
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. 4506.T | 28 | $691 |
| Endo USA, Inc. | 19 | $447 |
| Astellas Pharma US Inc 4503.T | 13 | $334 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 9 | $258 |
| Janssen Biotech, Inc. JNJ | 10 | $209 |
| Medtronic, Inc. MDT | 1 | $165 |
| Abbvie Inc. ABBV | 6 | $149 |
| Teleflex LLC TFX | 3 | $78.61 |
| Merck Sharp & Dohme LLC MRK | 3 | $76.48 |
| Ferring Pharmaceuticals Inc. | 3 | $70.65 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.